Precision is vital for the clinical decision making process that is supported by the measuring result of a biomarker. This requires both a stable and well-defined biomarker assay and a platform that safeguards a reliable and precise measurement of the biomarker. Our platform B·R·A·H·M·S KRYPTOR compact PLUS is a fully automatic, closed laboratory analysis system that can perform numerous various analyses in random-access operations using a unique measuring principle called TRACE (Time Resolved Amplified Cryptate Emission). TRACE is based on a research for which the French chemist Jean-Marie Lehn received a Nobel Prize in Chemistry in 1987.
Thermo Scientific B·R·A·H·M·S Biomarkers are proud to employ TRACE technology in their KRYPTOR instruments worldwide, based on an exclusive license. Precision technology paves the way for the development of innovative in-vitro diagnostic reagents for diverse clinical areas.
TRACE technology is the Nobel Prize-winning chemistry underlying the precision and usability of the B·R·A·H·M·S KRYPTOR compact PLUS. TRACE simplifies assay processing and ensures that only signals of interest are detected.